Allyse MA, Meagher K, Michie M, Isasi R, Ormond KE, Bonhomme N, Bombard Y, Musunuru K, Riggan KA, Rubeck S. Translational justice in human gene editing: bringing end user engagement and policy together. Am J Bioeth. 2023. In press.

Other Articles from our Team:

Ethics of Gene Editing:

Ormond KE, Bombard Y, Bonham VL, Hoffman-Andrews L, Howard H, Isasi R, Musunuru K, Riggan, KA, Michie, M, Allyse, M. The clinical application of gene editing: ethical and social issues. Per Med. 2019;16:337-350.

Patient Views on Gene Editing:

Riggan KA, Nyquist C, Michie M, Allyse M. Evaluating the risks and benefits of genetic and pharmacologic interventions for Down syndrome: views of parents. Am J Intellect. Dev. Disabil. 2020;125:1-13.

Michie M, Allyse M. Gene modification therapies: views of parents of people with Down syndrome. Genet. Med. 21, 487–492 (2019).

Hoffman-Andrews L, Mazzoni R, Pacione M, Garland-Thomson R, Ormond KE. Attitudes of people with inherited retinal conditions toward gene editing technology. Mol. Genet. Genomic Med. doi: 10.1002/mgg3.803 

Snure Beckman E, Deuitch N, Michie M, Allyse MA, Riggan KA, Ormond KE. Attitudes Toward Hypothetical Uses of Gene-Editing Technologies in Parents of People with Autosomal Aneuploidies. CRISPR J. 2019;2:324-330.